BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND CRTC1, Q6UUV9, 23373, ENSG00000105662, KIAA0616, TORC1, MECT1, WAMTP1, FLJ14027
18 results:

  • 1. MED15::ATF1-Rearranged Tumor: A Novel Cutaneous Tumor With Melanocytic Differentiation.
    Ko JS; Lemahieu J; Billings SD; Tirode F; Payton D; Boone B; Pissaloux D; de la Fouchardiere A
    Mod Pathol; 2024 Apr; 37(4):100438. PubMed ID: 38278485
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. One step at a time: Melanocytic differentiation in fusion-driven cutaneous neoplasms.
    Linos K
    J Cutan Pathol; 2023 Dec; 50(12):1116-1118. PubMed ID: 37844955
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Emerging mesenchymal tumour types and biases in the era of ubiquitous sequencing.
    Towery EA; Papke DJ
    J Clin Pathol; 2023 Dec; 76(12):802-812. PubMed ID: 37550012
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Gene fusions in superficial mesenchymal neoplasms: Emerging entities and useful diagnostic adjuncts.
    Fischer GM; Papke DJ
    Semin Diagn Pathol; 2023 Jul; 40(4):246-257. PubMed ID: 37156707
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cutaneous Melanocytic Tumor With crtc1::TRIM11 Translocation : An Emerging Entity Analyzed in a Series of 41 Cases.
    Hanna J; Ko JS; Billings SD; Boivin F; Beaudoux O; Pissaloux D; Tirode F; Laga A; Fletcher CDM; de la Fouchardiere A
    Am J Surg Pathol; 2022 Nov; 46(11):1457-1466. PubMed ID: 35993578
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cutaneous melanocytic tumor with crtc1::TRIM11 fusion and prominent epidermal involvement: A case report.
    Vest BE; Harview CL; Liu V; Swick BL; Berrebi KG; Olivares S; Stone MS; Sargen MR; Gerami P
    J Cutan Pathol; 2022 Dec; 49(12):1025-1030. PubMed ID: 35751643
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Statistical analysis plan for the Dual mTorc Inhibition in advanCed/recurrent Epithelial ovarian, fallopian tube or primary peritoneal cancer (of clear cell, endometrioid and high-grade serous type, and carcinosarcoma) trial (DICE).
    de la Rosa CN; Krell J; Day E; Clarke A; Reddi M; Webber L; Fiorentino F
    Trials; 2022 Jan; 23(1):13. PubMed ID: 34986897
    [TBL] [Abstract] [Full Text] [Related]  

  • 8.
    Pan R; Wang Z; Wang X; Fang R; Xia Q; Rao Q
    Int J Surg Pathol; 2022 Feb; 30(1):99-105. PubMed ID: 34057377
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Synergistic activity of mtorc1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity.
    Arnold A; Yuan M; Price A; Harris L; Eberhart CG; Raabe EH
    Neuro Oncol; 2020 Apr; 22(4):563-574. PubMed ID: 31841591
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. KIT-Dependent and KIT-Independent Genomic Heterogeneity of Resistance in Gastrointestinal Stromal Tumors - torc1/2 Inhibition as Salvage Strategy.
    Mühlenberg T; Ketzer J; Heinrich MC; Grunewald S; Marino-Enriquez A; Trautmann M; Hartmann W; Wardelmann E; Treckmann J; Worm K; Bertram S; Herold T; Schildhaus HU; Glimm H; Stenzinger A; Brors B; Horak P; Hohenberger P; Fröhling S; Fletcher JA; Bauer S
    Mol Cancer Ther; 2019 Nov; 18(11):1985-1996. PubMed ID: 31308077
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A case report of cutaneous melanocytoma with crtc1-TRIM11 fusion: Is CMCT distinct from clear cell sarcoma of soft tissue?
    Kashima J; Motoi T; Nishimaki M; Hayashi Y; Ogawa M; Kato I; Yamada R; Tonooka A; Horiguchi SI; Funata N; Hishima T; Yoshino K
    Pathol Int; 2019 Aug; 69(8):496-501. PubMed ID: 31276279
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. crtc1-TRIM11 fusion defined melanocytic tumors: A series of four cases.
    Ko JS; Wang L; Billings SD; Pissaloux D; Tirode F; Berry R; De La Fouchardiere A
    J Cutan Pathol; 2019 Nov; 46(11):810-818. PubMed ID: 31237704
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genetic analyses of undifferentiated small round cell sarcoma identifies a novel sarcoma subtype with a recurrent crtc1-SS18 gene fusion.
    Alholle A; Karanian M; Brini AT; Morris MR; Kannappan V; Niada S; Niblett A; Ranchère-Vince D; Pissaloux D; Delfour C; Maran-Gonzalez A; Antonescu CR; Sumathi V; Tirode F; Latif F
    J Pathol; 2018 Jun; 245(2):186-196. PubMed ID: 29533464
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cutaneous Melanocytoma With crtc1-TRIM11 Fusion: Report of 5 Cases Resembling Clear Cell Sarcoma.
    Cellier L; Perron E; Pissaloux D; Karanian M; Haddad V; Alberti L; de la Fouchardière A
    Am J Surg Pathol; 2018 Mar; 42(3):382-391. PubMed ID: 29240581
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Calcium signalling links MYC to NUAK1.
    Monteverde T; Tait-Mulder J; Hedley A; Knight JR; Sansom OJ; Murphy DJ
    Oncogene; 2018 Feb; 37(8):982-992. PubMed ID: 29106388
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Positive feedback regulation between microRNA-132 and CREB in spinal cord contributes to bone cancer pain in mice.
    Hou B; Cui X; Liu Y; Zhang W; Liu M; Sun YE; Ma Z; Gu X
    Eur J Pain; 2016 Sep; 20(8):1299-308. PubMed ID: 26919478
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo.
    Renshaw J; Taylor KR; Bishop R; Valenti M; De Haven Brandon A; Gowan S; Eccles SA; Ruddle RR; Johnson LD; Raynaud FI; Selfe JL; Thway K; Pietsch T; Pearson AD; Shipley J
    Clin Cancer Res; 2013 Nov; 19(21):5940-51. PubMed ID: 23918606
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Fusion oncogenes and tumor type specificity--insights from salivary gland tumors.
    Stenman G
    Semin Cancer Biol; 2005 Jun; 15(3):224-35. PubMed ID: 15826837
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.